Books > Professional & Technical > Biochemical engineering > Biotechnology
|
Buy Now
Advancing Development of Synthetic Gene Regulators - With the Power of High-Throughput Sequencing in Chemical Biology (Hardcover, 1st ed. 2018)
Loot Price: R3,190
Discovery Miles 31 900
|
|
Advancing Development of Synthetic Gene Regulators - With the Power of High-Throughput Sequencing in Chemical Biology (Hardcover, 1st ed. 2018)
Series: Springer Theses
Expected to ship within 12 - 17 working days
|
This book focuses on an "outside the box" notion by utilizing the
powerful applications of next-generation sequencing (NGS)
technologies in the interface of chemistry and biology. In
personalized medicine, developing small molecules targeting a
specific genomic sequence is an attractive goal. N-methylpyrrole
(P)-N-methylimidazole (I) polyamides (PIPs) are a class of small
molecule that can bind to the DNA minor groove. First, a
cost-effective NGS (ion torrent platform)-based Bind-n-Seq was
developed to identify the binding specificity of PIP conjugates in
a randomized DNA library. Their biological influences rely
primarily on selective DNA binding affinity, so it is important to
analyze their genome-wide binding preferences. However, it is
demanding to enrich specifically the small-molecule-bound DNA
without chemical cross-linking or covalent binding in chromatinized
genomes. Herein is described a method that was developed using
high-throughput sequencing to map the differential binding sites
and relative enriched regions of non-cross-linked SAHA-PIPs
throughout the complex human genome. SAHA-PIPs binding motifs were
identified and the genome-level mapping of SAHA-PIPs-enriched
regions provided evidence for the differential activation of the
gene network. A method using high-throughput sequencing to map the
binding sites and relative enriched regions of alkylating PIP
throughout the human genome was also developed. The genome-level
mapping of alkylating the PIP-enriched region and the binding sites
on the human genome identifies significant genomic targets of
breast cancer. It is anticipated that this pioneering low-cost,
high through-put investigation at the sequence-specific level will
be helpful in understanding the binding specificity of various
DNA-binding small molecules, which in turn will be beneficial for
the development of small-molecule-based drugs targeting a
genome-level sequence.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.